ACTIVE

BRUPHARM PHARMALAB

Financial year 2024 · closed on 31/12/2024
Net result
-45,1 k €
+60.0% YoY
Revenue
49,9 k €
+7.0% YoY
Equity
-112,9 k €
-66.5% YoY

What does BRUPHARM PHARMALAB do?

BRUPHARM PHARMALAB is a Private limited company incorporated in 2022. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Mons.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0785.641.404
Incorporation
03/05/2022
Legal form
Private limited company
Registered office
Route de Wallonie (G.) 140
7011 Mons · WallonieSee on map
Contributed capital
100 000,00 €
Latest accounts
31/12/2024
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 3 financial years

202420232022
Income statement
Revenue49,9 k €46,7 k €58,7 k €
EBITDA-6,7 k €-73,8 k €-31,5 k €
Operating result-44,6 k €-111,7 k €-54,9 k €
Net result-45,1 k €-112,7 k €-55,1 k €
Balance sheet
Equity-112,9 k €-67,8 k €44,9 k €
Total assets243,8 k €308,8 k €377,4 k €
Cash77,1 €2,3 k €22,7 k €
Debts356,7 k €376,6 k €332,5 k €
Governance

Board of directors

Seen on filing of 31/12/2024 · 1 active

Active mandates

ERIC VANDECAUTER

Mandate

Active
At this address

Other companies at this address

CompanyCBE no.
0418.543.914
EURO-M HOLDINGActive
0676.674.374
HEDELABActive
0462.055.144
NUTWAYActive
0503.901.043
Annual accounts

Full financial information

202420232022
Type of accountMicro modelMicro modelMicro model
Start of the financial year01/01/202401/01/202303/05/2022
Closing of the financial year31/12/202431/12/202331/12/2022
Length of the financial year12 months12 months8 months
Filing date07/11/202507/11/202518/04/2024
General meeting09/06/202510/06/202412/06/2023
Currency of the financial yearEUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

3 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202409/06/202507/11/2025FrenchPDF
Micro model31/12/202310/06/202407/11/2025FrenchPDF
Micro model31/12/202212/06/202318/04/2024FrenchPDF
Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2024 · 1 active

Active mandates

ERIC VANDECAUTER

Mandate

Active
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Other05/05/2022
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 2024-45,1 k €
  2. 2023
    Annual accounts 2023-112,7 k €
  3. 2022
    Annual accounts 2022-55,1 k €
  4. 03/05/2022
    IncorporationPrivate limited company